Off-Label Marketing Puts Novartis in Hot Water – Sold to Children and is a Carcinogen
Off-Label Marketing Puts Novartis in Hot Water By ROSE BOUBOUSHIAN (CN) - Novartis Pharmaceuticals must face claims that it promoted the use on infants of a drug that U.S. regulators…
You must be logged in to post a comment.